SEMPRA (SRE) Fundamental Analysis & Valuation

NYSE:SRE • US8168511090

Current stock price

95.88 USD
+0.34 (+0.36%)
At close:
95 USD
-0.88 (-0.92%)
Pre-Market:

This SRE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. SRE Profitability Analysis

1.1 Basic Checks

  • In the past year SRE was profitable.
  • SRE had a positive operating cash flow in the past year.
  • In the past 5 years SRE has always been profitable.
  • SRE had a positive operating cash flow in each of the past 5 years.
SRE Yearly Net Income VS EBIT VS OCF VS FCFSRE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B -4B 6B -6B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.62%, SRE is doing worse than 84.62% of the companies in the same industry.
  • SRE has a worse Return On Equity (5.68%) than 84.62% of its industry peers.
  • With a Return On Invested Capital value of 2.14%, SRE is not doing good in the industry: 96.15% of the companies in the same industry are doing better.
  • Measured over the past 3 years, the Average Return On Invested Capital for SRE is in line with the industry average of 3.74%.
Industry RankSector Rank
ROA 1.62%
ROE 5.68%
ROIC 2.14%
ROA(3y)2.67%
ROA(5y)2.49%
ROE(3y)8.42%
ROE(5y)7.56%
ROIC(3y)2.45%
ROIC(5y)2.49%
SRE Yearly ROA, ROE, ROICSRE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • The Profit Margin of SRE (13.11%) is better than 73.08% of its industry peers.
  • In the last couple of years the Profit Margin of SRE has declined.
  • SRE's Operating Margin of 22.48% is fine compared to the rest of the industry. SRE outperforms 61.54% of its industry peers.
  • SRE's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 22.48%
PM (TTM) 13.11%
GM N/A
OM growth 3Y8.27%
OM growth 5Y-2.04%
PM growth 3Y-3.31%
PM growth 5Y-16.91%
GM growth 3YN/A
GM growth 5YN/A
SRE Yearly Profit, Operating, Gross MarginsSRE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. SRE Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so SRE is destroying value.
  • Compared to 1 year ago, SRE has more shares outstanding
  • SRE has more shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, SRE has an improved debt to assets ratio.
SRE Yearly Shares OutstandingSRE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M
SRE Yearly Total Debt VS Total AssetsSRE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B 80B 100B

2.2 Solvency

  • SRE has an Altman-Z score of 1.05. This is a bad value and indicates that SRE is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 1.05, SRE belongs to the top of the industry, outperforming 80.77% of the companies in the same industry.
  • A Debt/Equity ratio of 1.05 is on the high side and indicates that SRE has dependencies on debt financing.
  • SRE has a Debt to Equity ratio of 1.05. This is amongst the best in the industry. SRE outperforms 96.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF N/A
Altman-Z 1.05
ROIC/WACC0.32
WACC6.76%
SRE Yearly LT Debt VS Equity VS FCFSRE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B 30B

2.3 Liquidity

  • SRE has a Current Ratio of 1.59. This is a normal value and indicates that SRE is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Current ratio value of 1.59, SRE belongs to the best of the industry, outperforming 96.15% of the companies in the same industry.
  • SRE has a Quick Ratio of 1.57. This is a normal value and indicates that SRE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Quick ratio of SRE (1.57) is better than 96.15% of its industry peers.
Industry RankSector Rank
Current Ratio 1.59
Quick Ratio 1.57
SRE Yearly Current Assets VS Current LiabilitesSRE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10B 20B 30B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. SRE Growth Analysis

3.1 Past

  • The Earnings Per Share has been growing slightly by 2.16% over the past year.
  • Measured over the past 5 years, SRE shows a small growth in Earnings Per Share. The EPS has been growing by 3.52% on average per year.
  • The Revenue has been growing slightly by 3.92% in the past year.
  • SRE shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.80% yearly.
EPS 1Y (TTM)2.16%
EPS 3Y0.83%
EPS 5Y3.52%
EPS Q2Q%-14.67%
Revenue 1Y (TTM)3.92%
Revenue growth 3Y-1.73%
Revenue growth 5Y3.8%
Sales Q2Q%-0.24%

3.2 Future

  • SRE is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 8.88% yearly.
  • SRE is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.45% yearly.
EPS Next Y9.09%
EPS Next 2Y8.76%
EPS Next 3Y8.51%
EPS Next 5Y8.88%
Revenue Next Year2.74%
Revenue Next 2Y-0.55%
Revenue Next 3Y0.53%
Revenue Next 5Y-0.45%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
SRE Yearly Revenue VS EstimatesSRE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B
SRE Yearly EPS VS EstimatesSRE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6

More info and screens

Find the best growth stocksShow best growing peers

1

4. SRE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 20.31, which indicates a rather expensive current valuation of SRE.
  • Based on the Price/Earnings ratio, SRE is valued a bit more expensive than 69.23% of the companies in the same industry.
  • SRE is valuated at similar levels of the S&P average when we compare the Price/Earnings ratio to 24.89, which is the current average of the S&P500 Index.
  • SRE is valuated rather expensively with a Price/Forward Earnings ratio of 18.62.
  • Based on the Price/Forward Earnings ratio, SRE is valued a bit more expensive than 69.23% of the companies in the same industry.
  • When comparing the Price/Forward Earnings ratio of SRE to the average of the S&P500 Index (22.19), we can say SRE is valued inline with the index average.
Industry RankSector Rank
PE 20.31
Fwd PE 18.62
SRE Price Earnings VS Forward Price EarningsSRE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, SRE is valued expensively inside the industry as 92.31% of the companies are valued cheaper.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.56
SRE Per share dataSRE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30 40

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)2.23
PEG (5Y)5.77
EPS Next 2Y8.76%
EPS Next 3Y8.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. SRE Dividend Analysis

5.1 Amount

  • With a Yearly Dividend Yield of 2.75%, SRE has a reasonable but not impressive dividend return.
  • With a Dividend Yield of 2.75, SRE pays less dividend than the industry average, which is at 3.45. 84.62% of the companies listed in the same industry pay a better dividend than SRE!
  • Compared to an average S&P500 Dividend Yield of 1.89, SRE pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 2.75%

5.2 History

  • The dividend of SRE decreases each year by -11.29%.
  • SRE has paid a dividend for at least 10 years, which is a reliable track record.
  • As SRE did not decrease their dividend in the past 5 years, we can say the dividend looks stable.
Dividend Growth(5Y)-11.29%
Div Incr Years7
Div Non Decr Years7
SRE Yearly Dividends per shareSRE Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • SRE pays out 91.48% of its income as dividend. This is not a sustainable payout ratio.
DP91.48%
EPS Next 2Y8.76%
EPS Next 3Y8.51%
SRE Yearly Income VS Free CF VS DividendSRE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B -4B -6B
SRE Dividend Payout.SRE Dividend Payout, showing the Payout Ratio.SRE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

SRE Fundamentals: All Metrics, Ratios and Statistics

SEMPRA

NYSE:SRE (3/27/2026, 8:04:00 PM)

Premarket: 95 -0.88 (-0.92%)

95.88

+0.34 (+0.36%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)02-26
Earnings (Next)05-06
Inst Owners94.08%
Inst Owner Change-2.08%
Ins Owners0.04%
Ins Owner Change-3.76%
Market Cap62.64B
Revenue(TTM)13.70B
Net Income(TTM)1.80B
Analysts78.26
Price Target104.43 (8.92%)
Short Float %1.57%
Short Ratio2.57
Dividend
Industry RankSector Rank
Dividend Yield 2.75%
Yearly Dividend2.52
Dividend Growth(5Y)-11.29%
DP91.48%
Div Incr Years7
Div Non Decr Years7
Ex-Date03-19
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.36%
Min EPS beat(2)8.22%
Max EPS beat(2)20.49%
EPS beat(4)4
Avg EPS beat(4)10.23%
Min EPS beat(4)4.16%
Max EPS beat(4)20.49%
EPS beat(8)4
Avg EPS beat(8)1.35%
EPS beat(12)8
Avg EPS beat(12)2.29%
EPS beat(16)12
Avg EPS beat(16)4.13%
Revenue beat(2)1
Avg Revenue beat(2)-0.62%
Min Revenue beat(2)-8.34%
Max Revenue beat(2)7.1%
Revenue beat(4)1
Avg Revenue beat(4)-2.3%
Min Revenue beat(4)-8.34%
Max Revenue beat(4)7.1%
Revenue beat(8)1
Avg Revenue beat(8)-11.75%
Revenue beat(12)2
Avg Revenue beat(12)-5.28%
Revenue beat(16)5
Avg Revenue beat(16)-2.27%
PT rev (1m)2.31%
PT rev (3m)2.38%
EPS NQ rev (1m)1.17%
EPS NQ rev (3m)3.09%
EPS NY rev (1m)-0.24%
EPS NY rev (3m)-0.16%
Revenue NQ rev (1m)-1.99%
Revenue NQ rev (3m)-1.08%
Revenue NY rev (1m)-1.53%
Revenue NY rev (3m)-3.01%
Valuation
Industry RankSector Rank
PE 20.31
Fwd PE 18.62
P/S 4.57
P/FCF N/A
P/OCF 13.72
P/B 1.98
P/tB 1.98
EV/EBITDA 16.56
EPS(TTM)4.72
EY4.92%
EPS(NY)5.15
Fwd EY5.37%
FCF(TTM)-10.83
FCFYN/A
OCF(TTM)6.99
OCFY7.29%
SpS20.97
BVpS48.39
TBVpS48.39
PEG (NY)2.23
PEG (5Y)5.77
Graham Number71.69
Profitability
Industry RankSector Rank
ROA 1.62%
ROE 5.68%
ROCE 3.46%
ROIC 2.14%
ROICexc 2.14%
ROICexgc 2.14%
OM 22.48%
PM (TTM) 13.11%
GM N/A
FCFM N/A
ROA(3y)2.67%
ROA(5y)2.49%
ROE(3y)8.42%
ROE(5y)7.56%
ROIC(3y)2.45%
ROIC(5y)2.49%
ROICexc(3y)2.46%
ROICexc(5y)2.51%
ROICexgc(3y)2.51%
ROICexgc(5y)2.57%
ROCE(3y)3.9%
ROCE(5y)4%
ROICexgc growth 3Y-3.39%
ROICexgc growth 5Y-7.53%
ROICexc growth 3Y-2.5%
ROICexc growth 5Y-6.96%
OM growth 3Y8.27%
OM growth 5Y-2.04%
PM growth 3Y-3.31%
PM growth 5Y-16.91%
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.12
Health
Industry RankSector Rank
Debt/Equity 1.05
Debt/FCF N/A
Debt/EBITDA 5.87
Cap/Depr 454.27%
Cap/Sales 84.97%
Interest Coverage 2.13
Cash Conversion 80.9%
Profit Quality N/A
Current Ratio 1.59
Quick Ratio 1.57
Altman-Z 1.05
F-Score6
WACC6.76%
ROIC/WACC0.32
Cap/Depr(3y)410.76%
Cap/Depr(5y)370.89%
Cap/Sales(3y)69.3%
Cap/Sales(5y)59.26%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2.16%
EPS 3Y0.83%
EPS 5Y3.52%
EPS Q2Q%-14.67%
EPS Next Y9.09%
EPS Next 2Y8.76%
EPS Next 3Y8.51%
EPS Next 5Y8.88%
Revenue 1Y (TTM)3.92%
Revenue growth 3Y-1.73%
Revenue growth 5Y3.8%
Sales Q2Q%-0.24%
Revenue Next Year2.74%
Revenue Next 2Y-0.55%
Revenue Next 3Y0.53%
Revenue Next 5Y-0.45%
EBIT growth 1Y3.98%
EBIT growth 3Y6.4%
EBIT growth 5Y1.69%
EBIT Next Year94.32%
EBIT Next 3Y27%
EBIT Next 5Y18.33%
FCF growth 1Y-68.64%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-6.97%
OCF growth 3Y58.71%
OCF growth 5Y11.99%

SEMPRA / SRE Fundamental Analysis FAQ

What is the fundamental rating for SRE stock?

ChartMill assigns a fundamental rating of 3 / 10 to SRE.


Can you provide the valuation status for SEMPRA?

ChartMill assigns a valuation rating of 1 / 10 to SEMPRA (SRE). This can be considered as Overvalued.


Can you provide the profitability details for SEMPRA?

SEMPRA (SRE) has a profitability rating of 3 / 10.


What is the valuation of SEMPRA based on its PE and PB ratios?

The Price/Earnings (PE) ratio for SEMPRA (SRE) is 20.31 and the Price/Book (PB) ratio is 1.98.


Is the dividend of SEMPRA sustainable?

The dividend rating of SEMPRA (SRE) is 3 / 10 and the dividend payout ratio is 91.48%.